Literature DB >> 21068284

Emergence of erythromycin- and clindamycin-resistant Streptococcus pyogenes emm 90 strains in Hawaii.

Iris Chen1, Pakieli Kaufisi, Guliz Erdem.   

Abstract

We identified 12 erythromycin- and clindamycin-resistant emm 90 group A streptococcus (GAS) isolates during a retrospective invasive disease survey in Hawaii. A comparison with 20 type-matched isolates showed all resistant isolates to be emm 90.4b with the constitutive or inducible macrolide-lincosamide-streptogramin B resistance phenotype (cMLS(B) or iMLS(B)). All isolates had the same pulsed-field gel electrophoresis (PFGE) pattern, suggesting clonal spread.

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 21068284      PMCID： PMC3020461          DOI： 10.1128/JCM.02208-10

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  29 in total

Review 1.  Global emm type distribution of group A streptococci: systematic review and implications for vaccine development.

Authors:  Andrew C Steer; Irwin Law; Laisiana Matatolu; Bernard W Beall; Jonathan R Carapetis
Journal:  Lancet Infect Dis       Date:  2009-10       Impact factor: 25.071

2.  Macrolide-resistant Streptococcus pyogenes in the United States, 2002-2003.

Authors:  Sandra S Richter; Kristopher P Heilmann; Susan E Beekmann; Norma J Miller; Ashley L Miller; Cassie L Rice; Christopher D Doern; Sean D Reid; Gary V Doern
Journal:  Clin Infect Dis       Date:  2005-09-01       Impact factor: 9.079

3.  Molecular epidemiologic comparison of 2 unusual clusters of group a streptococcal necrotizing fasciitis in Hawaii.

Authors:  Guliz Erdem; Jacqueline M Ford; Rebecca Y Kanenaka; Lucienne Abe; Karen Yamaga; Paul V Effler
Journal:  Clin Infect Dis       Date:  2005-05-09       Impact factor: 9.079

4.  Genetic relatedness of group A streptococci of the newly designated serotype M90 causing a food-borne outbreak and sporadic infections.

Authors:  S Pournaras; A Efstratiou; J Douboyas; R C George; A Tsakris
Journal:  Epidemiol Infect       Date:  2000-10       Impact factor: 2.451

5.  Improved outcome of clindamycin compared with beta-lactam antibiotic treatment for invasive Streptococcus pyogenes infection.

Authors:  J Zimbelman; A Palmer; J Todd
Journal:  Pediatr Infect Dis J       Date:  1999-12       Impact factor: 2.129

6.  Unusual resistance patterns in macrolide-resistant Streptococcus pyogenes harbouring erm(A).

Authors:  Surbhi Malhotra-Kumar; Annarita Mazzariol; Liesbet Van Heirstraeten; Christine Lammens; Peter de Rijk; Giuseppe Cornaglia; Herman Goossens
Journal:  J Antimicrob Chemother       Date:  2008-10-24       Impact factor: 5.790

7.  Streptococcal emm types in Hawaii: a region with high incidence of acute rheumatic fever.

Authors:  Guliz Erdem; Carla Mizumoto; David Esaki; Lucienne Abe; Venu Reddy; Paul V Effler
Journal:  Pediatr Infect Dis J       Date:  2009-01       Impact factor: 2.129

8.  Emergence of high-level fluoroquinolone resistance in emm6 Streptococcus pyogenes and in vitro resistance selection with ciprofloxacin, levofloxacin and moxifloxacin.

Authors:  Surbhi Malhotra-Kumar; Liesbet Van Heirstraeten; Christine Lammens; Sabine Chapelle; Herman Goossens
Journal:  J Antimicrob Chemother       Date:  2009-03-11       Impact factor: 5.790

9.  Group A streptococcal isolates temporally associated with acute rheumatic fever in Hawaii: differences from the continental United States.

Authors:  Guliz Erdem; Carla Mizumoto; David Esaki; Venu Reddy; David Kurahara; Karen Yamaga; Lucienne Abe; Dwight Johnson; Kara Yamamoto; Edward L Kaplan
Journal:  Clin Infect Dis       Date:  2007-06-19       Impact factor: 9.079

10.  Higher rates of streptococcal colonization among children in the Pacific Rim Region correlates with higher rates of group A streptococcal disease and sequelae.

Authors:  G Erdem; S Sinclair; J R Marrone; T F I'atala; A Tuua; B Tuua; F Tuumua; A Dodd; C Mizumoto; L Medina
Journal:  Clin Microbiol Infect       Date:  2009-07-20       Impact factor: 8.067
View more
  4 in total

1.  Aminomethyl spectinomycins as therapeutics for drug-resistant respiratory tract and sexually transmitted bacterial infections.

Authors:  David F Bruhn; Samanthi L Waidyarachchi; Dora B Madhura; Dimitri Shcherbakov; Zhong Zheng; Jiuyu Liu; Yasser M Abdelrahman; Aman P Singh; Stefan Duscha; Chetan Rathi; Robin B Lee; Robert J Belland; Bernd Meibohm; Jason W Rosch; Erik C Böttger; Richard E Lee
Journal:  Sci Transl Med       Date:  2015-05-20       Impact factor: 17.956

2.  Antibiotic susceptibility of streptococcus pyogenes isolated from respiratory tract infections in dakar, senegal.

Authors:  Makhtar Camara; Assane Dieng; Cheikh Saad Bouh Boye
Journal:  Microbiol Insights       Date:  2013-10-29

3.  Molecular characterization and evaluation of the emerging antibiotic-resistant Streptococcus pyogenes from eastern India.

Authors:  Dipanwita Ray; Somnath Saha; Sukanta Sinha; Nishith Kumar Pal; Basudev Bhattacharya
Journal:  BMC Infect Dis       Date:  2016-12-12       Impact factor: 3.090

Review 4.  Group A streptococcus endocarditis in children: 2 cases and a review of the literature.

Authors:  Nao Ogura; Kouki Tomari; Tomotada Takayama; Naoya Tonegawa; Teppei Okawa; Takashi Matsuoka; Mami Nakayashiro; Tsutomu Matsumora
Journal:  BMC Infect Dis       Date:  2019-01-31       Impact factor: 3.090
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.